Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brett Theeler

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Neuro-Oncology Practice|November 17, 2022
Exploring the prevalence and burden of sleep disturbance in primary brain tumor patientsAmanda L King, Dorela D Shuboni-Mulligan, Elizabeth Vera, et al.
Eclinicalmedicine|November 17, 2022
Relationship between RANO-PRO Working Group standardised priority constructs and disease progression among malignant glioma patients: A retrospective cohort studyElizabeth Vera, Alexa Christ, Ewa Grajkowska, et al.
NPJ Precision Oncology|August 14, 2025
A review of diffuse hemispheric glioma, H3 G34-mutant disease development, DNA repair, microenvironment, and treatments on the horizonCameron Crowell, Ziwen Zhu, Yingxiang Li, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Neuro-Oncology Practice|November 17, 2022
Exploring the prevalence and burden of sleep disturbance in primary brain tumor patientsAmanda L King, Dorela D Shuboni-Mulligan, Elizabeth Vera, et al.
Eclinicalmedicine|November 17, 2022
Relationship between RANO-PRO Working Group standardised priority constructs and disease progression among malignant glioma patients: A retrospective cohort studyElizabeth Vera, Alexa Christ, Ewa Grajkowska, et al.
NPJ Precision Oncology|August 14, 2025
A review of diffuse hemispheric glioma, H3 G34-mutant disease development, DNA repair, microenvironment, and treatments on the horizonCameron Crowell, Ziwen Zhu, Yingxiang Li, et al.
Pageof 2